Literature DB >> 25445523

Quality by Design approach to understand the physicochemical phenomena involved in controlled release of captopril SR matrix tablets.

J Saurí1, D Millán2, J M Suñé-Negre3, H Colom3, J R Ticó3, M Miñarro3, P Pérez-Lozano3, E García-Montoya3.   

Abstract

The aim of this study is to obtain swelling controlled release matrix tablets of captopril using the Quality by Design methodology (ICH Q8) and to know the transport mechanisms involved in captopril release. To obtain the area of knowledge, the design of experiments studying the effect of two components (HPMC K15M and ethylcellulose) at different levels has been applied, with the captopril dissolution profile as the product's most important critical quality attribute (CQA). Different dissolution profiles have been obtained with the design of experiments performed, which is a key factor in the development of controlled release matrix tablets. Kinetic analysis according to the equations of Higuchi and Korsmeyer-Peppas demonstrates that the release mechanism is a mechanism of erosion when the whole percentage of the polymer is ethylcellulose, and a diffusion mechanism when the whole percentage of the polymer is HPMC K15M. The physico-chemical characteristics of the gel layer determine the release rate of captopril. The thickness of the gel layer, the porosity which is formed in the matrix upon contact with water, pore size, the swelling rate, the erosion rate of the matrix, and the physico-chemical characteristics of captopril, are factors related to the kinetic equations described and that allow us to predict the release mechanism of captopril. A new relationship of the kinetic equations governing the in vitro behavior with the physical characteristics of the gel layer of the different formulations has been established. This study shows that the size of water-filled pores and the degree of crosslinking between the chains of HPMC K15M of the matrix are related to the exponent n of the Korsmeyer-Peppas equation and the type of transport of the captopril from within the matrix to the dissolution medium, that is, if the transport is only through water-filled pores, or if a combination of diffusion occurs through water-filled pores with a transport through continuous polymeric networks.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug release mechanism; Front movements; Image analysis; Matrix tablets; Quality by Design; Swelling controlled release

Mesh:

Substances:

Year:  2014        PMID: 25445523     DOI: 10.1016/j.ijpharm.2014.10.050

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  Development of a sustained-release microcapsule for delivery of metoprolol succinate.

Authors:  Li Song; Shengjiang He; Qineng Ping
Journal:  Exp Ther Med       Date:  2017-03-21       Impact factor: 2.447

2.  Risk assessment and experimental design in the development of a prolonged release drug delivery system with paliperidone.

Authors:  Sonia Iurian; Luana Turdean; Ioan Tomuta
Journal:  Drug Des Devel Ther       Date:  2017-03-13       Impact factor: 4.162

3.  Chitosan Spray-Dried Microparticles for Controlled Delivery of Venlafaxine Hydrochloride.

Authors:  Inmaculada Aranaz; Ines Paños; Carlos Peniche; Ángeles Heras; Niuris Acosta
Journal:  Molecules       Date:  2017-11-15       Impact factor: 4.411

4.  A Direct Compression Matrix Made from Xanthan Gum and Low Molecular Weight Chitosan Designed to Improve Compressibility in Controlled Release Tablets.

Authors:  Deeb Abu Fara; Suha M Dadou; Iyad Rashid; Riman Al-Obeidi; Milan D Antonijevic; Babur Z Chowdhry; Adnan Badwan
Journal:  Pharmaceutics       Date:  2019-11-12       Impact factor: 6.321

5.  Encapsulation of erythromycin and bacitracin antibiotics into natural sporopollenin microcapsules: antibacterial, cytotoxicity, in vitro and in vivo release studies for enhanced bioavailability.

Authors:  Amro K F Dyab; Mohamed A Mohamed; Noha M Meligi; Shaaban K Mohamed
Journal:  RSC Adv       Date:  2018-09-27       Impact factor: 4.036

6.  Formulation and Evaluation of Linum usitatissimum Mucilage-Based Nanoparticles for Effective Delivery of Ezetimibe.

Authors:  Ume Ruqia Tulain; Arshad Mahmood; Sidra Aslam; Alia Erum; Nadia Shamshad Malik; Ayesha Rashid; Rizwana Kausar; Mohammed S Alqahtani
Journal:  Int J Nanomedicine       Date:  2021-07-05

7.  Formulation and evaluation of docetaxel nanosuspensions: In-vitro evaluation and cytotoxicity.

Authors:  Mohamed A Ibrahim; Gamal A Shazly; Fadilah S Aleanizy; Fulwah Y Alqahtani; Gehan M Elosaily
Journal:  Saudi Pharm J       Date:  2018-07-20       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.